Markets
Sensex · Nifty · NSE · BSE
marketsWaterways Leisure Tourism's IPO, parent of Cordelia Cruises, may list at a discount according to GMP trends. Investors can verify allotment status through the registrar's website. The listing date is yet to be confirmed.
marketsThe IPO of Cordelia Cruises, parent of Waterways Leisure Tourism, is expected to list at a discount according to the latest GMP. Investors can check allotment status via BSE or the registrar's portal. The listing date will be announced soon.
marketsAdvit Jewels' IPO was oversubscribed 213 times, receiving bids for over 178 crore shares against 83.79 lakh offered. The issue was priced between Rs 130 and Rs 138 per share, indicating strong investor interest.
marketsAdvit Jewels' IPO was oversubscribed 213 times, with bids for over 178 crore shares against 83.79 lakh offered. The issue, priced between Rs 130 and Rs 138 per share, reflects strong investor interest. The allotment status can be checked online, and the listing date is eagerly awaited.
marketsAs Bitcoin struggles, tokenised assets are gaining traction, offering investors new avenues for returns. With projections of a $2.7 trillion to $8.2 trillion market by 2030, the tokenisation industry is set to transform finance.
marketsTurtlemint's Rs 883 crore IPO, priced at Rs 152 per share, received a 1.24 times subscription, driven by institutional demand. The company plans to use the proceeds to enhance technology and expand operations.
marketsAnubhav Plast's IPO has seen strong demand, with significant oversubscription in the NII and QIB segments. The company plans to use the proceeds to expand its manufacturing capabilities.
marketsAastha Spintex's IPO opens today, with plans to fund the acquisition of Falcon Yarns and enhance operations. The company has shown strong financial growth and aims to expand its spinning capacity significantly.
marketsAdon Agro Commodities is launching an IPO, requiring a minimum investment of Rs 2.8 lakh. The company, known for its 'Hunger Nuts' brand, plans to use the proceeds to boost working capital. With significant financial growth and an expanding customer base, the IPO is a strategic move to support further expansion.
marketsTwinkle Papers has launched its IPO today, with retail investors required to bid for a minimum of 4,000 shares. The company aims to use the proceeds for expansion and growth. Established in 1995, Twinkle Papers has shown steady financial improvement, with significant revenue and profit growth in recent years.
marketsGlobal markets reacted to US-Iran talks with S&P 500 and Nasdaq 100 futures rising. Asian shares slipped, and oil prices fluctuated amid Middle East tensions. Investors remain cautious about potential risks and upcoming economic indicators.
marketsOil prices have risen as renewed U.S.-Iran tensions in the Middle East impact shipments through the Strait of Hormuz. Brent crude futures increased by 0.672%, while West Texas Intermediate crude rose by 1.03%. The market is reassessing the potential for a swift recovery in oil supply.
marketsForeign portfolio investors have reduced their outflows from Indian equities in June, driven by easing geopolitical tensions and supportive measures from the RBI. While domestic investors continue their buying spree, sustained foreign inflows depend on stronger earnings and economic growth.
marketsChina and India's largest firms have seen a decline in market cap share, now at 19%, as AI-driven growth propels markets in Taiwan and South Korea. While diversified markets like India lag, they may offer stability if AI spending cycles cool.
marketsThe Nifty index showed volatility amid the BSE F&O expiry, yet maintained a positive trend by staying above the 50-day EMA. India VIX fell by 2.05%, indicating reduced market fear, while the rupee strengthened slightly. Foreign investors were net sellers, whereas domestic investors were net buyers.
marketsShares of Waaree Energies, HDFC Bank, and Strides Pharma are in focus today due to significant corporate developments. Waaree Energies cleared a US investigation, while HDFC Bank's former chairman questioned a legal review. Strides Pharma divested a stake in Pivot Path.
marketsThe Indian stock market posted gains last week, driven by a drop in crude oil prices and optimism over an India-US trade deal. The Sensex rose 0.39% to 77,100.47, while the Nifty added 0.18% to 24,056. Investors are closely watching geopolitical developments and the progress of the southwest monsoon.
marketsU.S. markets closed lower as tech stocks, particularly AI-related chipmakers, weighed on investor sentiment. Inflation concerns persist with Apple's price hikes, while Moderna surged after showcasing its pipeline. The potential delay of OpenAI's IPO also impacted AI stock sentiment.
marketsUS markets closed lower on Thursday, led by declines in tech stocks amid concerns over AI-related chipmakers and inflation. Apple partially rebounded after price hikes, while Moderna surged following an investor event. Inflation and interest rate concerns continue to weigh on investor sentiment.
marketsLingyi, an Apple supplier, saw its shares rise 6% on its first day of trading in Hong Kong, opening at HK$10.80 compared to an offer price of HK$10.18. The strong debut reflects investor confidence in the company's growth prospects.
marketsReformation, a sustainable fashion brand, reported a revenue increase to $507.1 million for 2025, despite a drop in net profit. The company plans to go public on the NYSE, aiming to capitalize on the revived U.S. IPO market.
marketsBrokerages have recommended stocks in sectors like cement and electronics, highlighting potential upsides of 10-23%. Key picks include Ambuja Cements, Dixon Technologies, and Polycab India.
marketsAsian stocks fell as tech shares faced volatility, with South Korea's Kospi dropping 3%. Oil prices rose following geopolitical tensions, while bond traders adjusted Fed rate hike expectations. Investors are concerned about tech giants' ability to meet high expectations.
marketsLaurus Labs is shifting focus to higher-value segments, with CDMO now contributing over 30% to revenue, expected to reach 50% by FY30. The company is expanding into non-pharma areas and planning significant capital expenditure to boost manufacturing capacity.